Breaking News, Collaborations & Alliances

Pall Enters Cell and Gene Therapy Mfg. Tie-up with NJII

Will invest $3.5 million in new innovation partnership

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) Corporation, has signed an Industry Participation Agreement with Pall Corporation to support the development of its BioPharmaceutical Innovation iLab.   The partnership will support two key centers at NJII that will advance the manufacturing of new cell and gene therapies: the Cell and Gene Therapy Development Center and the Center of Advanced Biologic Manufacturing.   “We are excited to work with Pall ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters